Skip to main content
. 2021 Sep 29;13(19):4877. doi: 10.3390/cancers13194877

Figure 5.

Figure 5

Overall survival with favorable “Top Survivor” biomarker expression (high SIRT1, low TOP2A) compared to other biomarker combinations.